Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Symbol: 002603.SZ
SHZ
19.58
CNYMarktpreis heute
12.0881
P/E-Verhältnis
1.2606
PEG-Verhältnis
32.71B
MRK Kapital
- 0.03%
DIV Rendite
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603-SZ) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 8322.47 | 2422.7 | 1050.5 | 1554 | |||||||||||||||
balance-sheet.row.short-term-investments | 2554.79 | 518.4 | 55.3 | 217 | |||||||||||||||
balance-sheet.row.net-receivables | 11259.24 | 2699.6 | 2593.1 | 2102.4 | |||||||||||||||
balance-sheet.row.inventory | 9782.92 | 2021.8 | 1672.7 | 1580.3 | |||||||||||||||
balance-sheet.row.other-current-assets | 631.46 | 110.1 | 285.8 | 222.7 | |||||||||||||||
balance-sheet.row.total-current-assets | 29996.09 | 7254.2 | 5602.1 | 5459.4 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 26574.19 | 6221.8 | 5745.5 | 4299.1 | |||||||||||||||
balance-sheet.row.goodwill | 228.47 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.intangible-assets | 3445.29 | 828 | 897.9 | 736.6 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3673.77 | 828 | 897.9 | 736.6 | |||||||||||||||
balance-sheet.row.long-term-investments | 4655.45 | 830.5 | -54.3 | -216 | |||||||||||||||
balance-sheet.row.tax-assets | 820.62 | 279.9 | 117 | 137.8 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 4451.29 | 921.8 | 596.6 | 1075.3 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 40175.32 | 9081.9 | 7302.7 | 6032.9 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 70171.42 | 16336.1 | 12904.8 | 11492.3 | |||||||||||||||
balance-sheet.row.account-payables | 10015.9 | 2060.8 | 1621.2 | 1188.4 | |||||||||||||||
balance-sheet.row.short-term-debt | 3422.6 | 656.3 | 513.9 | 270.2 | |||||||||||||||
balance-sheet.row.tax-payables | 1098.62 | 474 | 123.2 | 133.9 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 1455.8 | 215.1 | 513 | 10.5 | |||||||||||||||
Deferred Revenue Non Current | 1400.88 | 335 | 357.8 | 328.1 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 263.2 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 1781.83 | 1027.3 | 216.3 | 28.3 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 3119.87 | 555.7 | 872.2 | 330.1 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 54.95 | 15 | 12.5 | 10.5 | |||||||||||||||
balance-sheet.row.total-liab | 23563.79 | 5405.8 | 3832.7 | 2569 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 6682.82 | 1670.7 | 1670.7 | 1203.7 | |||||||||||||||
balance-sheet.row.retained-earnings | 26853.23 | 5989.2 | 4306.2 | 4324.4 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 8524.94 | 989 | 808.9 | 640.9 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 4566.63 | 2283.3 | 2283.3 | 2750.3 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 46627.62 | 10932.2 | 9069.1 | 8919.3 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 70171.42 | 16336.1 | 12904.8 | 11492.3 | |||||||||||||||
balance-sheet.row.minority-interest | -19.99 | -1.9 | 3 | 4.1 | |||||||||||||||
balance-sheet.row.total-equity | 46607.63 | 10930.3 | 9072.2 | 8923.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 70171.42 | - | - | - | |||||||||||||||
Total Investments | 7210.24 | 1348.9 | 1 | 1 | |||||||||||||||
balance-sheet.row.total-debt | 4878.39 | 871.4 | 1026.9 | 270.2 | |||||||||||||||
balance-sheet.row.net-debt | -889.29 | -1032.8 | 31.6 | -1066.8 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 2706.16 | 2356.8 | 1341.6 | 1214.9 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 121.87 | 451.5 | 362.9 | 268.2 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -158.7 | 20.1 | -67.7 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 158.7 | -20.1 | 67.7 | |||||||||||||||
cash-flows.row.change-in-working-capital | -1179.67 | 547.8 | -1309.7 | 24.8 | |||||||||||||||
cash-flows.row.account-receivables | -831.66 | -831.7 | -1280.3 | -668.7 | |||||||||||||||
cash-flows.row.inventory | -348.01 | -348 | -104.7 | -364.9 | |||||||||||||||
cash-flows.row.account-payables | 22.82 | 1886.2 | 55.1 | 1126.1 | |||||||||||||||
cash-flows.row.other-working-capital | -22.82 | -158.7 | 20.1 | -67.7 | |||||||||||||||
cash-flows.row.other-non-cash-items | 245.91 | 131.6 | 133.9 | 78.3 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1894.27 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -246.9 | -214 | -673.6 | -1144.8 | |||||||||||||||
cash-flows.row.acquisitions-net | -628.54 | 0.4 | 2.4 | 1145.1 | |||||||||||||||
cash-flows.row.purchases-of-investments | -5902.36 | -3461.9 | -451 | -2853.3 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 4047.54 | 1680.7 | 616.6 | 2957.6 | |||||||||||||||
cash-flows.row.other-investing-activites | 0.36 | 0 | -1.2 | -1144.8 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -2729.91 | -1994.8 | -506.8 | -1040.2 | |||||||||||||||
cash-flows.row.debt-repayment | -1250 | -2200 | -1469.9 | -270 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | -413.64 | -282.7 | -1220.1 | -244.1 | |||||||||||||||
cash-flows.row.other-financing-activites | 1321.67 | 1845.7 | 2387.9 | 490.8 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -341.96 | -637 | -302.1 | -23.3 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.28 | 1.2 | -0.5 | -2 | |||||||||||||||
cash-flows.row.net-change-in-cash | -663.1 | 857.2 | -280.7 | 520.8 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 5395.81 | 1810.7 | 953.5 | 1234.2 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 6058.9 | 953.5 | 1234.2 | 713.4 | |||||||||||||||
cash-flows.row.operating-cash-flow | 1894.27 | 3487.7 | 528.7 | 1586.2 | |||||||||||||||
cash-flows.row.capital-expenditure | -246.9 | -214 | -673.6 | -1144.8 | |||||||||||||||
cash-flows.row.free-cash-flow | 1647.37 | 3273.8 | -144.9 | 441.4 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 13161.66 | 12532.8 | 10116.8 | 8782.5 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 4867.04 | 4540.6 | 3681 | 3118.4 | |||||||||||||||
income-statement-row.row.gross-profit | 8294.62 | 7992.3 | 6435.8 | 5664.1 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 1074.04 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 235.76 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3177.48 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 505.39 | 576.9 | 366.6 | 323 | |||||||||||||||
income-statement-row.row.operating-expenses | 4982.24 | 5025.8 | 4758.7 | 4179.2 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 9849.29 | 9566.4 | 8439.7 | 7297.6 | |||||||||||||||
income-statement-row.row.interest-income | 14.34 | 12.9 | 20.4 | 7 | |||||||||||||||
income-statement-row.row.interest-expense | 36.75 | 33.8 | 34 | 3.8 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3177.48 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | -20.99 | -48.9 | -15.4 | -15.6 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 505.39 | 576.9 | 366.6 | 323 | |||||||||||||||
income-statement-row.row.total-operating-expenses | -20.99 | -48.9 | -15.4 | -15.6 | |||||||||||||||
income-statement-row.row.interest-expense | 36.75 | 33.8 | 34 | 3.8 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 100.71 | 546.1 | 448.6 | 329.5 | |||||||||||||||
income-statement-row.row.ebitda-caps | 3303.32 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 3202.61 | 2829.6 | 1569.1 | 1438 | |||||||||||||||
income-statement-row.row.income-before-tax | 3181.62 | 2780.6 | 1553.7 | 1422.5 | |||||||||||||||
income-statement-row.row.income-tax-expense | 482.98 | 423.8 | 212.1 | 207.5 | |||||||||||||||
income-statement-row.row.net-income | 2706.16 | 2361.8 | 1343.9 | 1218.7 |
Häufig gestellte Frage
Wie hoch ist die Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) Gesamtvermögen?
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) Gesamtvermögen ist 16336112689.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 4639721722.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.630.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 0.986.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.206.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.243.
Was ist der Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 2361804714.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 871449540.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 5025828583.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 1072618858.000.